Pillar5 Pharma, Inc. recently underwent a successful GMP inspection by Health Canada. The inspection covered solid dose and aseptic manufacturing, and all quality systems. Pillar5 Pharma was issued a compliant rating by Health Canada’s Health Products and Food Branch.

“Receiving another compliant rating from Health Canada is a testament to the high level of attention paid to our quality processes and to the experience and technical knowledge of our employees,” said president and chief executive officer John Carkner.